Altimmune, Inc. (ALT) Tops Q4 EPS by 7c

Altimmune, Inc. (NASDAQ: ALT) reported Q4 EPS of ($0.43), $0.07 better than the analyst estimate of ($0.50).

For earnings history and earnings-related data on Altimmune, Inc. (ALT) click here.

You May Also Be Interested In

• SanDisk and Micron surge as Apple confirms memory price pass-through
• Goldman starts Talen at buy, sees PJM power tightness boosting earnings
• JPMorgan Upgrades SHIFT UP Corp (462870:KS) to Overweight